{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:03:22Z","timestamp":1792029802802,"version":"4.4.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T00:00:00Z","timestamp":1634169600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010447","name":"Deutsches Zentrum f\u00fcr Herz-Kreislaufforschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010447","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["AL2054\/1-1"],"award-info":[{"award-number":["AL2054\/1-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["VO2259\/2-1"],"award-info":[{"award-number":["VO2259\/2-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01KG1202"],"award-info":[{"award-number":["01KG1202"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["FP7\/2007-2013\u2013603288-SysVasc"],"award-info":[{"award-number":["FP7\/2007-2013\u2013603288-SysVasc"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017268","name":"Berlin Institute of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.bbrc.2021.10.023","type":"journal-article","created":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T08:01:47Z","timestamp":1633939307000},"page":"28-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Protective effects of spironolactone on vascular calcification in chronic kidney disease"],"prefix":"10.1016","volume":"582","author":[{"given":"Fabian","family":"Hammer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore S.","family":"Buehling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaber","family":"Masyout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Malzahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7097-2815","authenticated-orcid":false,"given":"Tobias","family":"Hauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilman","family":"Auer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f6ren","family":"Grebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Feger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashad","family":"Tuffaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9961-1084","authenticated-orcid":false,"given":"Gerald","family":"Degenhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Pasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana","family":"Alesutan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Wanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Krane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Voelkl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2021.10.023_bib1","first-page":"3162806","article-title":"Phosphate and cardiovascular disease beyond chronic kidney disease and vascular calcification","author":"Disthabanchong","year":"2018","journal-title":"Internet J. Nephrol."},{"key":"10.1016\/j.bbrc.2021.10.023_bib2","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/eci.12493","article-title":"Arteriosclerosis and vascular calcification: causes, clinical assessment and therapy","volume":"45","author":"Tolle","year":"2015","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.bbrc.2021.10.023_bib3","first-page":"2077","article-title":"Signaling pathways involved in vascular smooth muscle cell calcification during hyperphosphatemia","volume":"76","author":"Voelkl","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbrc.2021.10.023_bib4","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.kint.2017.11.035","article-title":"Pyrophosphate deficiency in vascular calcification","volume":"93","author":"Villa-Bellosta","year":"2018","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbrc.2021.10.023_bib5","first-page":"9182078","article-title":"Phosphate, calcification in blood, and mineral stress: the physiologic blood mineral buffering system and its association with cardiovascular risk","author":"Pasch","year":"2018","journal-title":"Internet J. Nephrol."},{"key":"10.1016\/j.bbrc.2021.10.023_bib6","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/ki.2010.390","article-title":"Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in\u00a0vitro","volume":"79","author":"Sage","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbrc.2021.10.023_bib7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.bone.2018.02.023","article-title":"Biochemical transformation of calciprotein particles in uraemia","volume":"110","author":"Smith","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.bbrc.2021.10.023_bib8","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1681\/ASN.2012030240","article-title":"Nanoparticle-based test measures overall propensity for calcification in serum","volume":"23","author":"Pasch","year":"2012","journal-title":"J.\u00a0Am. Soc. Nephrol. : JASN (J. Am. Soc. Nephrol.)"},{"key":"10.1016\/j.bbrc.2021.10.023_bib9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2215\/CJN.04720416","article-title":"Blood calcification propensity, cardiovascular events, and survival in patients receiving hemodialysis in the EVOLVE trial","volume":"12","author":"Pasch","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbrc.2021.10.023_bib10","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1038\/s41598-017-01882-2","article-title":"Involvement of vascular aldosterone synthase in phosphate-induced osteogenic transformation of vascular smooth muscle cells","volume":"7","author":"Alesutan","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2021.10.023_bib11","first-page":"812","article-title":"Spironolactone ameliorates PIT1-dependent vascular osteoinduction in klotho-hypomorphic mice","volume":"123","author":"Voelkl","year":"2013","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.bbrc.2021.10.023_bib12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000368268","article-title":"Impact of aldosterone on osteoinductive signaling and vascular calcification","volume":"128","author":"Lang","year":"2014","journal-title":"Nephron. Physiol."},{"key":"10.1016\/j.bbrc.2021.10.023_bib13","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1161\/HYPERTENSIONAHA.117.10644","article-title":"Downregulated serum 14, 15-epoxyeicosatrienoic acid is associated with abdominal aortic calcification in patients with primary aldosteronism","volume":"71","author":"Liu","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.bbrc.2021.10.023_bib14","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.kint.2018.11.025","article-title":"A\u00a0randomized controlled trial of the effect of spironolactone on left ventricular mass in hemodialysis patients","volume":"95","author":"Hammer","year":"2019","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbrc.2021.10.023_bib15","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jacc.2013.09.056","article-title":"Spironolactone reduces cardiovascular and cerebrovascular morbidity and mortality in hemodialysis patients","volume":"63","author":"Matsumoto","year":"2014","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.bbrc.2021.10.023_bib16","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1172\/JCI96477","article-title":"SGK1 induces vascular smooth muscle cell calcification through NF-kappaB signaling","volume":"128","author":"Voelkl","year":"2018","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.bbrc.2021.10.023_bib17","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1681\/ASN.2017050492","article-title":"Zinc inhibits phosphate-induced vascular calcification through TNFAIP3-mediated suppression of NF-kappaB","volume":"29","author":"Voelkl","year":"2018","journal-title":"J.\u00a0Am. Soc. Nephrol. : JASN (J. Am. Soc. Nephrol.)"},{"key":"10.1016\/j.bbrc.2021.10.023_bib18","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1159\/000355728","article-title":"25-Hydroxyvitamin D3 1-alpha-hydroxylase-dependent stimulation of renal klotho expression by spironolactone","volume":"37","author":"Alesutan","year":"2013","journal-title":"Kidney Blood Pres. Res."},{"key":"10.1016\/j.bbrc.2021.10.023_bib19","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/cvr\/cvw062","article-title":"Augmentation of phosphate-induced osteo-\/chondrogenic transformation of vascular smooth muscle cells by homoarginine","volume":"110","author":"Alesutan","year":"2016","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbrc.2021.10.023_bib20","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/HJH.0000000000001202","article-title":"Inhibition of osteo\/chondrogenic transformation of vascular smooth muscle cells by MgCl2 via calcium-sensing receptor","volume":"35","author":"Alesutan","year":"2017","journal-title":"J.\u00a0Hypertens."},{"key":"10.1016\/j.bbrc.2021.10.023_bib21","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/j.bbrc.2018.07.161","article-title":"Role of PKB\/SGK-dependent phosphorylation of GSK-3alpha\/beta in vascular calcification during cholecalciferol overload in mice","volume":"503","author":"Tuffaha","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2021.10.023_bib22","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1159\/000368524","article-title":"Inhibition of phosphate-induced vascular smooth muscle cell osteo-\/chondrogenic signaling and calcification by bafilomycin A1 and methylamine","volume":"40","author":"Alesutan","year":"2015","journal-title":"Kidney Blood Pres. Res."},{"key":"10.1016\/j.bbrc.2021.10.023_bib23","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1159\/000430380","article-title":"SGK1-Sensitive regulation of Cyclin-dependent Kinase inhibitor 1B (p27) in Cardiomyocyte hypertrophy, Cellular physiology and biochemistry","volume":"37","author":"Voelkl","year":"2015","journal-title":"Int. J. Exp.Cell. Physiol. Biochem.Pharmacol."},{"key":"10.1016\/j.bbrc.2021.10.023_bib24","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1471-2288-13-92","article-title":"A\u00a0tutorial on sensitivity analyses in clinical trials: the what, why, when and how","volume":"13","author":"Thabane","year":"2013","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.bbrc.2021.10.023_bib25","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1002\/(SICI)1097-0258(19980815\/30)17:15\/16<1863::AID-SIM989>3.0.CO;2-M","article-title":"Issues for covariance analysis of dichotomous and ordered categorical data from randomized clinical trials and non-parametric strategies for addressing them","volume":"17","author":"Koch","year":"1998","journal-title":"Stat. Med."},{"key":"10.1016\/j.bbrc.2021.10.023_bib26","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1053\/j.ajkd.2019.01.024","article-title":"Serum calcification propensity and coronary artery calcification among patients with CKD: the CRIC (chronic renal insufficiency cohort) study","volume":"73","author":"Bundy","year":"2019","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bbrc.2021.10.023_bib27","doi-asserted-by":"crossref","first-page":"13368","DOI":"10.1038\/s41598-017-12859-6","article-title":"Worsening calcification propensity precedes all-cause and cardiovascular mortality in haemodialyzed patients","volume":"7","author":"Lorenz","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2021.10.023_bib28","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1681\/ASN.2013060635","article-title":"Serum calcification propensity predicts all-cause mortality in predialysis CKD","volume":"25","author":"Smith","year":"2014","journal-title":"J.\u00a0Am. Soc. Nephrol. : JASN (J. Am. Soc. Nephrol.)"},{"key":"10.1016\/j.bbrc.2021.10.023_bib29","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/ajt.13443","article-title":"Serum calcification propensity is a strong and independent determinant of cardiac and all-cause mortality in kidney transplant recipients","volume":"16","author":"Dahle","year":"2016","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.bbrc.2021.10.023_bib30","doi-asserted-by":"crossref","first-page":"F967","DOI":"10.1152\/ajprenal.00669.2014","article-title":"Spironolactone ameliorates arterial medial calcification in uremic rats: the role of mineralocorticoid receptor signaling in vascular calcification","volume":"309","author":"Tatsumoto","year":"2015","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.bbrc.2021.10.023_bib31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1258\/ebm.2011.011175","article-title":"Endogenous aldosterone is involved in vascular calcification in rat","volume":"237","author":"Wu","year":"2012","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.bbrc.2021.10.023_bib32","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1002\/jcp.25935","article-title":"End stage renal disease-induced hypercalcemia may promote aortic valve calcification via Annexin VI enrichment of valve interstitial cell derived-matrix vesicles","volume":"232","author":"Cui","year":"2017","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.bbrc.2021.10.023_bib33","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.3892\/mmr.2016.5484","article-title":"Silencing of osterix expression by siRNA inhibits aldosteroneinduced calcification of vascular smooth muscle cells in mice","volume":"14","author":"Gong","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbrc.2021.10.023_bib34","first-page":"3622","article-title":"Spironolactone dosedependently alleviates the calcification of aortic rings cultured in hyperphosphatemic medium with or without hyperglycemia by suppressing phenotypic transition of VSMCs through downregulation of Pit1","volume":"19","author":"Wang","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbrc.2021.10.023_bib35","first-page":"3431597","article-title":"The Crosstalk between calcium ions and aldosterone Contributes to inflammation, apoptosis, and calcification of VSMC via the AIF-1\/NF-kappaB pathway in uremia","author":"Hao","year":"2020","journal-title":"Oxid Med Cell Longev"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X21014248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X21014248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:11:14Z","timestamp":1757765474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X21014248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":35,"alternative-id":["S0006291X21014248"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2021.10.023","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective effects of spironolactone on vascular calcification in chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2021.10.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}